Navigation Links
Commercial Manufacturing of H1N1 'Swine Flu' Vaccine Underway
Date:6/15/2009

man clinical trials of an H1N1 vaccine. Such studies will evaluate different doses, two dosing regimes and an adjuvanted formulation of the vaccine.

About PSC

PSC is a privately held biopharmaceutical company based in Meriden, Connecticut, whose mission it is to save lives and improve health, by effectively responding to our changing world with innovative vaccines and biopharmaceuticals. PSC uses recombinant DNA technology to make novel human and veterinary prophylactic and therapeutic vaccines and diagnostics. The active ingredients in all of the firm's products are recombinant proteins that are manufactured, using its patented protein expression technology, based upon baculovirus and insect cell technology.

PSC's lead product is FluBlok(R), a seasonal recombinant trivalent influenza vaccine consisting of influenza hemagglutinin proteins. FluBlok is manufactured without the use of eggs, is highly purified and, therefore, does not require the use of thimerosal or antibiotics, and is low in endotoxins. PSC filed a Biologics License Application for FluBlok with the FDA in April 2008 that is currently undergoing final review. PSC anticipates that FluBlok will receive FDA approval in time for the 2009/2010 influenza season.


'/>"/>
SOURCE Protein Sciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
2. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
3. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
4. ADVENTRX Appoints Vice President of Commercialization
5. Pharmaceutical Product Launch: Commercially Focused R&D Increases Drugs Market Potential
6. Accera, Inc. Names William T. Poncy Vice President of Commercial Development
7. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
8. Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol
9. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
10. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
11. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...,Who: David Appia, French Ambassador for Internati...t in France Agency, , , , ,What: Ambassador Appia... pro-business initiatives adopted by France to fur...ndscape for innovation and development., , ,When: ...
(Date:11/24/2009)...celand,November24/PRNewswire-FirstCall/--deCODE,ge...eceivednoticefrom,theNasdaqStockMarketthattradingi...er30,2009andaForm25-NSEwillbefiledwiththe,Securiti...monstock,fromlistingonNasdaq,unlessthecompanyfiles...companyhasfiledsuchanappeal,which,willstaythesuspe...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--NODPharmaceuticalsInc.annou...dthepatentapplicationfor,itsnano-particleoraldeliv...fficientapproachtoincorporatepeptidesor,proteinsin...drugs,otherwiseadministeredasinjections.NODtechnol...romoleculardrugssuchasinsulin,interferon,growthho...
(Date:11/24/2009)... The FBI recently approved the Promega Power...ating in or generating DNA records for the Nationa...ison, WI USA (PRWEB) -- The FBI recently approved ...by laboratories participating in, or generating DN...). NDIS currently contains more than seven million...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2
...H, N.J., Jan. 9 Schering-Plough Corporation (NYSE...resentation by Thomas P. Koestler, Ph.D., executiv...search Institute, at the 27th Annual J.P. Morgan H...an. 12, at approximately 3:30 p.m. (PST) (6:30 p.m...mpany,s R&D pipeline and select projects in de...
...RD, Pa., Jan. 9 Endo Pharmaceuticals (Nasdaq: E...t and Chief Executive Officer of Endo, will presen...l Healthcare Conference on Wednesday, January 14, ...ill be held January 12-15, 2009 in San Francisco. ...tation may be accessed on the Endo Website at www...
...N, Ireland, January 9 Azur Pharma Limited ("Azur,...usive U.S. marketing rights,for Niravam(R) (alpraz...arbidopa-levodopa orally disintegrating tablets), ...s) and Fluxid(TM) (famotidine orally,disintegratin...ms were not,disclosed. , Niravam, Parcopa and ...
Other Biology Technology:Endo Pharmaceuticals to Present at the J.P. Morgan 27th Annual Healthcare Conference 2Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB 2
(Date:11/24/2009)...ch Institute (LRI) today named 12 new grant recipi...recognize innovative work across a broad spectrum ...ativity, novelty, and potential to drive scientifi... the complex disease of systemic lupus. , The 20...earchers across the nation and include interdiscip...
(Date:11/24/2009)... weakened and flabby arteries from collapsing have...e stents are no longer needed -- once the arteries...usly, doctors had no choice but to leave them in p...rsity,s Department of Biomedical Engineering has d...carries drugs where they,re needed, then dissolves...
(Date:11/24/2009)...NEW YORK (November 24, 2009) -- The Wildlife Conse...ealing that the last remaining population of Siber...o the rising tide of poaching and habitat loss. ,... Russian officials of what needs to be done to pro...cat. , The report was released by t...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3A coating for life 2Report shows dramatic decline in Siberian tigers 2Employment Policies Institute Launches 2410 Million Campaign Urging the Public to Rethink Health Care Reform 61198 1Employment Policies Institute Launches 2410 Million Campaign Urging the Public to Rethink Health Care Reform 61198 2Speedus Corp Names Stephen X Graham to Board of Directors 61195 1Speedus Corp Names Stephen X Graham to Board of Directors 61195 2Memphis Mayor Endorses National Bipolar Foundation 61190 1Memphis Mayor Endorses National Bipolar Foundation 61190 2
... rise in autoimmune diseases such as multiple scle...nvironmental factors could be the cause of this in...esis" in which an excessively germ-free environmen...s that a decline in infectious diseases may play a...The first study examining the relationship between...
...ysis of nicotine yield from major brand name cigar...confirmed that manufacturers have steadily increas...dependent analysis, based on data submitted to the...by the manufacturers, found that increases in smok...t each year, or about 11 percent over a seven-year...
... drugs (opioids) are commonly prescribed for short...tiveness long-term has been questioned in a review..., who also found that behaviors consistent with op... "Patients with chronic back pain commonly request...despite the concerns clinicians have with patients...
Other Biology News:Parasite infection may benefit MS patients 2Re-analysis of cigarettes confirms tobacco companies increased addictive nicotine 11 percent 2Re-analysis of cigarettes confirms tobacco companies increased addictive nicotine 11 percent 3
...the 4000 Q TRAP(TM) LC/MS/MS System, a high perfor...s spectrometer for the drug discovery, drug develo...Ion Trap (LIT) Technology from the leaders in mass...itative analysis with the proven, high sensitivity...
...d salt solution. It is routinely used as an antico...age of whole blood at refrigerator temperatures fo...ume of blood is collected into a container of this...lution is placed in a refrigerator at 2-8 C for 2 ...
Rabbit Anti-GST Polyclonal Antibody, Unconjugated from Novus Biologicals
Chicken Anti-GST Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: